Article
Mu-opioid receptor expression on B cells as a potential biomarker for chronic pain: a follow-up study with patients with fibromyalgia
27 May 2025
Abstract excerpt
Introduction: Before COVID-19 pandemic, we identified the percentage of B cells expressing the Mu-opioid receptor (Mu+ B cells) as a potential marker, named Mu-Lympho-Marker (MLM), for chronic pain (CP) in patients with fibromyalgia (FM) and osteoarthritis. Objectives: Here, we demonstrate the stability of MLM over time through a comparative analysis of biological, clinical, and psychological data collected from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
